Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Mexiletine for the Symptomatic Treatment of Myotonic Disorders – First Line	Mexiletine hydrochloride (Namuscla)	Myotonia	Musculoskeletal System , Neurology	2018	View \| Download
Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders	Mexiletine hydrochloride (Namuscla)	Myotonia	Genetic Disorders	2023	View \| Download
Migalastat for Fabry disease in children aged 12 to 15 years	Migalastat hydrochloride (Galafold; AT1001)	Fabry disease	Endocrine Nutritional and Metabolic Disorders , Genetic Disorders	2019	View \| Download
Mim8 for prophylaxis of haemophilia A	NNC0365-3769	Haemophilia A	Haematology	2023	View \| Download
Mirabegron for neurogenic detrusor overactivity in people aged 3 to 17 years	Mirabegron	Neurogenic detrusor overactivity	Neurology , Urology	2022	View \| Download
Mirikizumab for the treatment of moderately to severely active ulcerative colitis	Mirikizumab (LY3074828)	Ulcerative colitis	Gastroenterology	2021	View \| Download
Mirikizumab for treating moderately to severely active Crohn’s disease	Mirikizumab (LY3074828)	Crohn's disease	Gastroenterology , Immunology	2022	View \| Download
Mirvetuximab soravtansine for advanced, epithelial ovarian, fallopian tube, or primary peritoneal cancer with high folate receptor-alpha expression	Mirvetuximab soravtansine (IMGN853)	Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer	Female Reproductive Cancer	2023	View \| Download
Mirvetuximab Soravtansine for Platinum-resistant Ovarian Cancer	Mirvetuximab soravtansine (IMGN853)	Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer	Female Reproductive Cancer	2018	View \| Download
Mitapivat for treating pyruvate kinase deficiency	Mitapivat (AG-348)	Pyruvate kinase deficiency	Endocrine Nutritional and Metabolic Disorders	2020	View \| Download